Clinical Trials for Ovarian Cancer

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT ID: NCT06503146

This clinical trial is studying a new imaging method using a special substance called 18F-FAPI-74 to help detect certain types of cancer more effectively. The goal is to find out if this new tracer...

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

NCT ID: NCT03412877

This clinical trial is studying a new treatment for people with certain types of metastatic cancer, meaning the cancer has spread to other parts of the body and has not responded to standard therap...

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

NCT ID: NCT01441089

This clinical trial is studying how certain genes may affect the way people with cancer respond to treatment. Researchers believe that some genes can influence the side effects of treatment and how...

Early Phase Study of Kesonotide in Participants With Solid Tumours

NCT ID: NCT06926075

This clinical trial is studying a new treatment called kesonotide for patients with advanced solid tumors, such as prostate, breast, lung, ovarian cancers, and others. The main goal of the study is...

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT ID: NCT05891171

This clinical trial is studying a new treatment called AB598 for patients with advanced cancers, including types like bladder, cervical, lung, and breast cancer, among others. The main goal is to s...

Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT07156253

OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

NCT ID: NCT07153705

This clinical trial is looking at a new way to monitor ovarian cancer in women whose usual blood test (called CA125) doesn’t show signs of the cancer coming back after their first treatment. The st...

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

NCT ID: NCT05053230

The IM@HOME clinical trial is studying a program that offers virtual mind-body therapies to help people with certain types of cancer, including head and neck cancer, ovarian cancer, and melanoma, a...

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

NCT ID: NCT06253520

This clinical trial is exploring a new treatment for adults with advanced cancers that have spread, such as colorectal, breast, lung, gastrointestinal, ovarian, and genitourinary cancers. The goal ...

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

NCT ID: NCT03762733

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

NCT ID: NCT07023627

This clinical trial is studying a new drug called INCB123667 for women with a type of ovarian cancer that has stopped responding to standard platinum-based chemotherapy. Specifically, it focuses on...

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

NCT ID: NCT05922930

This clinical trial is testing a new treatment for patients with certain types of cancer, specifically those that have not responded to previous treatments. The study is looking at a special kind o...

AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer

NCT ID: NCT07146919

This clinical trial is studying a new combination of medicines called bemarituzimab and bevacizumab to treat three types of gynecological cancers: cancer of the uterus lining (endometrial cancer), ...

A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors

NCT ID: NCT06508307

This clinical trial is investigating a new treatment called GC001, which is an oncolytic virus designed to target and help fight advanced solid tumors, such as sarcoma, cervical cancer, colon cance...

Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

NCT ID: NCT06930755

This clinical trial is investigating a new treatment called NMS-03305293 combined with an existing medication, topotecan, for women with relapsed ovarian cancer. The main goal of the study is to se...

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT ID: NCT06257264

This clinical trial is studying a new treatment called BG-68501 for patients with advanced-stage tumors, including certain types of breast cancer, lung cancer, ovarian cancer, and others. The main ...

Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer

NCT ID: NCT05113368

This clinical trial is studying the effectiveness of a combination treatment using two medications, regorafenib and fulvestrant, for women with recurrent low-grade serous ovarian cancer. The goal i...

A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

NCT ID: NCT06888921

This clinical trial is studying a new treatment called COM701 to see if it can help women with relapsed platinum-sensitive ovarian cancer. The main goal is to find out if COM701 can slow down the p...

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

NCT ID: NCT06999187

This clinical trial is looking at a new treatment called DR-0202 for patients with certain types of advanced cancers, including triple-negative breast cancer and non-small cell lung cancer, among o...

Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study

NCT ID: NCT06935344

The PROVE Study is a research trial aimed at understanding how a specific genetic assessment, called a polygenic risk score (PRS), can help predict the risk of developing epithelial ovarian cancer ...